Target intelligence / Profile preview

MFF divergent transcript (MFF-DT)

Target: MFF-DT
Molecular classification: Other, Non-coding RNA

Overview

MFF divergent transcript (MFF-DT) is a non-coding RNA situated on human chromosome 2. It is transcribed antisense to the MFF gene but does not encode a protein, and there is currently no evidence supporting it as a molecular therapeutic target or functional disease biomarker. Its biological and pathological functions, if any, have not been characterized in peer-reviewed literature. The term "divergent transcript" generally refers to transcripts initiated in the opposite direction from a gene promoter, commonly resulting in non-coding RNAs that lack established functions and may reflect transcriptional noise or regulatory RNA biogenesis mechanisms[3][1][2][4].

Other names: MFF-DT

Beyond the preview

Go deeper on MFF divergent transcript (MFF-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MFF divergent transcript (MFF-DT).

Explore the full profile